CSPC Pharmaceutical Group (01093.HK) saw its stock price soar by 11.44% in intraday trading on Thursday, following the release of its impressive first-quarter financial results. The significant uptick in share value came shortly after the company announced its Q1 revenue and adjusted net income figures.

According to the released financial data, CSPC Pharmaceutical Group reported a robust Q1 revenue of RMB 7,015 million. This strong top-line performance was accompanied by an adjusted net income of RMB 1,411 million for the same period. These results appear to have exceeded market expectations, prompting a positive reaction from investors and driving the stock's substantial gain.

It's worth noting that there was an initial error in reporting the revenue figure, which was initially stated as RMB 608 million. However, this was quickly corrected to the accurate amount of RMB 7,015 million. The correction and confirmation of the higher revenue figure likely contributed to the investor enthusiasm and the subsequent stock price surge. The company's strong financial performance, despite challenging market conditions, suggests resilience in its business model and potential for future growth, which appears to have resonated well with the market.